Imidazole-based anticancer agents and derivatives thereof, and methods of making and using same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11098038
APP PUB NO 20200385374A1
SERIAL NO

16638587

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Imidazole-based anticancer agents and derivatives thereof, as well as methods of making and methods of using the same, are described. The imidazole-based anticancer agents are HDAC inhibitor compounds having a 1-(1H-imidazol-2-yl)ethan-1-one or 1-(1H-imidazol-2-yl)ethane-1-thione moiety.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNIVERSITY OF TOLEDO2801 W BANCROFT STREET TOLEDO OH 43606

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Al-Hamashi, Ayad Toledo, US 2 0
Alqahtani, Abdulateef Saeed S Toledo, US 1 0
Dlamini, Samkeliso Toledo, US 1 0
Karaj, Endri Toledo, US 3 0
Tillekeratne, Viranga Toledo, US 8 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 24, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 24, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 24, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00